Review
Published on 22 Dec 2022
Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1020188
- 17,066 views
- 40 citations
- Frontiers in Medicine
- Nuclear Medicine
- Articles
Type at least 3 characters
416 articles
Case Report
Published on 20 Dec 2022
Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1078560
- 2,416 views
- 9 citations
Review
Published on 16 Dec 2022
Targeted alpha therapy for glioblastoma
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1085245
- 6,014 views
- 16 citations
Editorial
Published on 12 Dec 2022
Editorial: Small animal imaging: Technological and methodological advances to improve the translational power
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1099233
- 1,462 views
Review
Published on 07 Dec 2022
Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1034315
- 15,620 views
- 38 citations
Review
Published on 06 Dec 2022
Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1060922
- 7,325 views
- 13 citations
Editorial
Published on 02 Dec 2022
Editorial: Case reports in PET imaging
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1087583
- 1,640 views
Brief Research Report
Published on 02 Dec 2022
Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1073720
- 1,928 views
- 5 citations
Brief Research Report
Published on 02 Dec 2022
Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1046551
- 2,792 views
- 8 citations
Mini Review
Published on 30 Nov 2022
18F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1070445
- 3,157 views
- 6 citations
![Radiation exposure to nuclear medicine technologists performing a V/Q PET: Comparison with conventional V/Q scintigraphy, [18F]FDG PET and [68Ga]Ga DOTATOC PET procedures](https://www.frontiersin.org/files/myhome article library/1051249/1051249_Thumb_400.jpg)
Original Research
Published on 30 Nov 2022
Radiation exposure to nuclear medicine technologists performing a V/Q PET: Comparison with conventional V/Q scintigraphy, [18F]FDG PET and [68Ga]Ga DOTATOC PET procedures
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1051249
- 2,070 views
- 2 citations
Original Research
Published on 25 Nov 2022
A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1050854
- 2,501 views
- 9 citations
Original Research
Published on 24 Nov 2022
Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1058455
- 3,631 views
- 6 citations
Case Report
Published on 24 Nov 2022
Different uptake patterns of 68Ga-FAPI in aseptic loosening and periprosthetic joint infection of hip arthroplasty: A case series and literature review
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1014463
- 3,964 views
- 6 citations
Original Research
Published on 23 Nov 2022
Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1058863
- 3,972 views
- 9 citations
![AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)](https://www.frontiersin.org/files/myhome article library/1059122/1059122_Thumb_400.jpg)
Study Protocol
Published on 18 Nov 2022
AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2022.1059122
- 10,701 views
- 35 citations